| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | TAP complex binding | 7.32e-08 | 9 | 100 | 4 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 7.32e-08 | 9 | 100 | 4 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.22e-07 | 10 | 100 | 4 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.22e-07 | 10 | 100 | 4 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.22e-07 | 10 | 100 | 4 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 2.84e-07 | 12 | 100 | 4 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.34e-06 | 17 | 100 | 4 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 2.70e-06 | 20 | 100 | 4 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.91e-05 | 32 | 100 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 5.73e-05 | 42 | 100 | 4 | GO:0071889 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.06e-04 | 49 | 100 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.04e-04 | 58 | 100 | 4 | GO:0042287 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 3.44e-08 | 8 | 99 | 4 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 8.69e-07 | 16 | 99 | 4 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.13e-06 | 17 | 99 | 4 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.13e-06 | 17 | 99 | 4 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.45e-06 | 18 | 99 | 4 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.45e-06 | 18 | 99 | 4 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 3.34e-06 | 48 | 99 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 4.12e-06 | 23 | 99 | 4 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 5.85e-06 | 25 | 99 | 4 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 5.85e-06 | 25 | 99 | 4 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 8.62e-06 | 58 | 99 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 1.62e-05 | 32 | 99 | 4 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 3.25e-05 | 76 | 99 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 4.41e-05 | 41 | 99 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 4.86e-05 | 42 | 99 | 4 | GO:0001916 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 1.22e-04 | 53 | 99 | 4 | GO:0001914 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 1.32e-04 | 233 | 99 | 7 | GO:0031345 | |
| GeneOntologyBiologicalProcess | regulation of protein autoubiquitination | 3.38e-04 | 6 | 99 | 2 | GO:1902498 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 3.59e-04 | 70 | 99 | 4 | GO:0001913 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 4.44e-04 | 74 | 99 | 4 | GO:0002711 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 1.71e-08 | 7 | 100 | 4 | GO:0032398 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 7.12e-08 | 23 | 100 | 5 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.01e-07 | 10 | 100 | 4 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 4.76e-07 | 14 | 100 | 4 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.12e-06 | 17 | 100 | 4 | GO:0033106 | |
| GeneOntologyCellularComponent | MHC protein complex | 6.80e-06 | 26 | 100 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 2.30e-05 | 35 | 100 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 4.80e-05 | 42 | 100 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 4.89e-05 | 83 | 100 | 5 | GO:0030670 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 7.20e-05 | 212 | 100 | 7 | GO:0030666 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 8.16e-05 | 48 | 100 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 2.51e-04 | 64 | 100 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | Golgi cisterna | 4.80e-04 | 135 | 100 | 5 | GO:0031985 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 5.89e-04 | 215 | 100 | 6 | GO:0030662 | |
| GeneOntologyCellularComponent | cis-Golgi network | 7.42e-04 | 85 | 100 | 4 | GO:0005801 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 9.51e-04 | 157 | 100 | 5 | GO:0045335 | |
| GeneOntologyCellularComponent | Golgi stack | 1.39e-03 | 171 | 100 | 5 | GO:0005795 | |
| GeneOntologyCellularComponent | coated vesicle | 1.72e-03 | 360 | 100 | 7 | GO:0030135 | |
| GeneOntologyCellularComponent | membrane raft | 1.78e-03 | 362 | 100 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 1.83e-03 | 364 | 100 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.93e-03 | 110 | 100 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.06e-03 | 112 | 100 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | Golgi membrane | HLA-A COPA HLA-C HLA-G HLA-H ST6GAL1 FTCD ABCB4 PIKFYVE FAM20C | 2.37e-03 | 721 | 100 | 10 | GO:0000139 |
| GeneOntologyCellularComponent | endocytic vesicle | 2.48e-03 | 384 | 100 | 7 | GO:0030139 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 3.07e-03 | 125 | 100 | 4 | GO:0140534 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 3.46e-03 | 519 | 100 | 8 | GO:0009897 | |
| GeneOntologyCellularComponent | early endosome membrane | 3.53e-03 | 212 | 100 | 5 | GO:0031901 | |
| MousePheno | spinal cord inflammation | 4.72e-08 | 8 | 73 | 4 | MP:0030987 | |
| MousePheno | abnormal NK cell number | 3.11e-05 | 172 | 73 | 7 | MP:0008043 | |
| MousePheno | abnormal T cell activation | 3.31e-05 | 311 | 73 | 9 | MP:0001828 | |
| MousePheno | decreased NK cell number | 3.76e-05 | 120 | 73 | 6 | MP:0008045 | |
| MousePheno | abnormal NK cell morphology | 4.62e-05 | 183 | 73 | 7 | MP:0005068 | |
| MousePheno | decreased immature NK cell number | 4.77e-05 | 14 | 73 | 3 | MP:0013666 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 8.67e-05 | 45 | 73 | 4 | MP:0004804 | |
| MousePheno | decreased mature NK cell number | 1.05e-04 | 18 | 73 | 3 | MP:0013672 | |
| MousePheno | abnormal immature NK cell number | 1.25e-04 | 19 | 73 | 3 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 1.25e-04 | 19 | 73 | 3 | MP:0013699 | |
| MousePheno | CNS inflammation | 1.78e-04 | 54 | 73 | 4 | MP:0006082 | |
| MousePheno | cystolithiasis | 1.96e-04 | 22 | 73 | 3 | MP:0011625 | |
| MousePheno | increased lymphocyte cell number | ZC3H12A HLA-A COPA HLA-C HLA-G BLNK HLA-H TNFRSF10A ABCB4 FZD1 SNRNP40 ELF4 SMCR8 | 2.18e-04 | 797 | 73 | 13 | MP:0005013 |
| MousePheno | abnormal mature NK cell number | 2.56e-04 | 24 | 73 | 3 | MP:0013671 | |
| MousePheno | abnormal mature NK cell morphology | 2.89e-04 | 25 | 73 | 3 | MP:0013700 | |
| MousePheno | abnormal urinary bladder morphology | 2.98e-04 | 247 | 73 | 7 | MP:0000538 | |
| Domain | MHC_I_a_C | 2.52e-06 | 6 | 95 | 3 | IPR010579 | |
| Domain | MHC_I_C | 2.52e-06 | 6 | 95 | 3 | PF06623 | |
| Domain | MHC_I | 3.52e-06 | 21 | 95 | 4 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 3.52e-06 | 21 | 95 | 4 | IPR001039 | |
| Domain | WD40_repeat_CS | 2.05e-05 | 164 | 95 | 7 | IPR019775 | |
| Domain | - | 5.00e-05 | 333 | 95 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 5.24e-05 | 335 | 95 | 9 | IPR015943 | |
| Domain | WD40 | 5.27e-05 | 259 | 95 | 8 | PF00400 | |
| Domain | WD40 | 6.70e-05 | 268 | 95 | 8 | SM00320 | |
| Domain | WD40_repeat | 7.43e-05 | 272 | 95 | 8 | IPR001680 | |
| Domain | WD_REPEATS_1 | 8.65e-05 | 278 | 95 | 8 | PS00678 | |
| Domain | WD_REPEATS_2 | 8.87e-05 | 279 | 95 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 8.87e-05 | 279 | 95 | 8 | PS50294 | |
| Domain | WD40_repeat_dom | 1.37e-04 | 297 | 95 | 8 | IPR017986 | |
| Domain | C1-set | 1.63e-04 | 54 | 95 | 4 | PF07654 | |
| Domain | IGc1 | 1.88e-04 | 56 | 95 | 4 | SM00407 | |
| Domain | Ig_C1-set | 2.16e-04 | 58 | 95 | 4 | IPR003597 | |
| Domain | Ig/MHC_CS | 2.16e-04 | 58 | 95 | 4 | IPR003006 | |
| Domain | - | 2.39e-04 | 24 | 95 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 2.39e-04 | 24 | 95 | 3 | IPR011161 | |
| Domain | IG_MHC | 2.46e-04 | 60 | 95 | 4 | PS00290 | |
| Domain | Haem_d1 | 3.79e-04 | 6 | 95 | 2 | IPR011048 | |
| Domain | MHC_I/II-like_Ag-recog | 9.45e-04 | 38 | 95 | 3 | IPR011162 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 5.10e-08 | 9 | 65 | 4 | MM14527 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 1.20e-06 | 18 | 65 | 4 | MM14525 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.85e-06 | 6 | 65 | 3 | M47468 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 1.89e-06 | 20 | 65 | 4 | MM1374 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 3.23e-06 | 7 | 65 | 3 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 3.23e-06 | 7 | 65 | 3 | M47530 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 4.84e-06 | 25 | 65 | 4 | MM1465 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 4.84e-06 | 25 | 65 | 4 | MM15713 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.50e-05 | 11 | 65 | 3 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.00e-05 | 12 | 65 | 3 | M47529 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.09e-04 | 54 | 65 | 4 | MM14871 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 3.14e-04 | 29 | 65 | 3 | M1062 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 4.12e-04 | 76 | 65 | 4 | MM14526 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 4.55e-04 | 78 | 65 | 4 | M973 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 6.50e-04 | 37 | 65 | 3 | M18615 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 8.80e-04 | 41 | 65 | 3 | M13519 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 1.01e-03 | 43 | 65 | 3 | M12617 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.07e-03 | 98 | 65 | 4 | M965 | |
| Pathway | KEGG_ENDOCYTOSIS | 1.46e-03 | 181 | 65 | 5 | M1519 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 6088985 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 1686840 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 1705528 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 2808323 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 21088134 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 34181639 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 69663 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 8206527 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 2.62e-09 | 7 | 104 | 4 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 2.62e-09 | 7 | 104 | 4 | 6264319 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3456611 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 15809355 | ||
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 2.62e-09 | 7 | 104 | 4 | 2714856 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 10500200 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 16210630 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 2.62e-09 | 7 | 104 | 4 | 2391419 | |
| Pubmed | Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. | 2.62e-09 | 7 | 104 | 4 | 3840195 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 15671142 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 14215561 | ||
| Pubmed | Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells. | 2.62e-09 | 7 | 104 | 4 | 1540549 | |
| Pubmed | Mouse histocompatibility genes: structure and organisation of a Kd gene. | 2.62e-09 | 7 | 104 | 4 | 11894934 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 19700752 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 2.62e-09 | 7 | 104 | 4 | 28234229 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 11894963 | ||
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 2.62e-09 | 7 | 104 | 4 | 6242891 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 16836618 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 22287714 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 17512611 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3997208 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3263465 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 7018573 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 2997361 | ||
| Pubmed | Expression of GM1 and GD1a in mouse liver is linked to the H-2 complex on chromosome 17. | 2.62e-09 | 7 | 104 | 4 | 6671979 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 18974374 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 9869916 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 16148128 | ||
| Pubmed | The role of the MHC on resistance to group a streptococci in mice. | 2.62e-09 | 7 | 104 | 4 | 16148132 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 312902 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 2642506 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 9037062 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 1840571 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 16476767 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 16148097 | ||
| Pubmed | Serological analysis of H-2 mutations using monoclonal antibodies. | 2.62e-09 | 7 | 104 | 4 | 6084033 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 20957233 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 2.62e-09 | 7 | 104 | 4 | 11086076 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 24101547 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 12682111 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3335396 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 12750360 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 6689056 | ||
| Pubmed | The multi-locus H-2Dw16 region has an organization distinct from the Dd region. | 2.62e-09 | 7 | 104 | 4 | 1348492 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 16461341 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 2.62e-09 | 7 | 104 | 4 | 20974936 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 10704462 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 6895187 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 22573867 | ||
| Pubmed | Genetic control of corticosteroid side-chain isomerase activity in the mouse. | 2.62e-09 | 7 | 104 | 4 | 6822218 | |
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 2.62e-09 | 7 | 104 | 4 | 2908875 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 15210799 | ||
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 2.62e-09 | 7 | 104 | 4 | 2584927 | |
| Pubmed | Studies of two H-2Db mutants: B6. C-H-2bm13 and B6.C-H-2bm14. | 2.62e-09 | 7 | 104 | 4 | 6159320 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3496275 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 12147629 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3458188 | ||
| Pubmed | NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection. | 2.62e-09 | 7 | 104 | 4 | 19820922 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 2.62e-09 | 7 | 104 | 4 | 1730883 | |
| Pubmed | Synapse elimination and learning rules co-regulated by MHC class I H2-Db. | 2.62e-09 | 7 | 104 | 4 | 24695230 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 8181071 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 2.62e-09 | 7 | 104 | 4 | 19004778 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 6300887 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 23142461 | ||
| Pubmed | Structure of C-terminal half of two H-2 antigens from cloned mRNA. | 2.62e-09 | 7 | 104 | 4 | 6895103 | |
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 2.62e-09 | 7 | 104 | 4 | 6300850 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3094964 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 8500526 | ||
| Pubmed | The nucleotide sequence and comparative analysis of the H-2Dp class I H-2 gene. | 2.62e-09 | 7 | 104 | 4 | 3082989 | |
| Pubmed | Expression of H-2K and H-2D genes by PYS-2 teratocarcinoma cells. | 2.62e-09 | 7 | 104 | 4 | 3202874 | |
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 2.62e-09 | 7 | 104 | 4 | 6265910 | |
| Pubmed | Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. | 2.62e-09 | 7 | 104 | 4 | 18453559 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 2.62e-09 | 7 | 104 | 4 | 2906539 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 7675041 | ||
| Pubmed | Nucleotide sequences of H2g7 K and D loci of nonobese diabetic mice. | 2.62e-09 | 7 | 104 | 4 | 7759137 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3013627 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 6799575 | ||
| Pubmed | Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice. | 2.62e-09 | 7 | 104 | 4 | 6966299 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 12140378 | ||
| Pubmed | Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. | 2.62e-09 | 7 | 104 | 4 | 11854356 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 2410925 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 11842259 | ||
| Pubmed | DNA sequence of the mouse H-2Dd transplantation antigen gene. | 2.62e-09 | 7 | 104 | 4 | 3856254 | |
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 12421934 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3894562 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 27385590 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 3840763 | ||
| Pubmed | 2.62e-09 | 7 | 104 | 4 | 12421940 | ||
| Interaction | ADAMTS13 interactions | 8.49e-06 | 26 | 102 | 4 | int:ADAMTS13 | |
| Interaction | CD8A interactions | 8.49e-06 | 26 | 102 | 4 | int:CD8A | |
| Interaction | LILRB1 interactions | 1.47e-05 | 10 | 102 | 3 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 1.47e-05 | 10 | 102 | 3 | int:LILRB2 | |
| Cytoband | 6p21.3 | 2.39e-05 | 250 | 104 | 6 | 6p21.3 | |
| GeneFamily | WD repeat domain containing | 4.32e-06 | 262 | 65 | 8 | 362 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.85e-05 | 44 | 65 | 4 | 588 | |
| GeneFamily | C1-set domain containing | 4.61e-04 | 42 | 65 | 3 | 591 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 3.95e-07 | 16 | 103 | 4 | MM3766 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 8.33e-07 | 19 | 103 | 4 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 8.33e-07 | 19 | 103 | 4 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.04e-06 | 20 | 103 | 4 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.28e-06 | 21 | 103 | 4 | MM651 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 2.25e-06 | 24 | 103 | 4 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 2.67e-06 | 25 | 103 | 4 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 6.52e-06 | 31 | 103 | 4 | MM3729 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 1.07e-05 | 35 | 103 | 4 | MM674 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.66e-05 | 39 | 103 | 4 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 1.66e-05 | 39 | 103 | 4 | MM3725 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 2.04e-05 | 41 | 103 | 4 | MM710 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 2.30e-05 | 86 | 103 | 5 | MM834 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 2.47e-05 | 43 | 103 | 4 | MM1204 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 2.57e-05 | 147 | 103 | 6 | MM3753 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 2.71e-05 | 44 | 103 | 4 | MM3775 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 2.87e-05 | 90 | 103 | 5 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 3.19e-05 | 92 | 103 | 5 | MM3748 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 3.23e-05 | 46 | 103 | 4 | MM3712 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 3.36e-05 | 93 | 103 | 5 | MM1185 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 4.16e-05 | 49 | 103 | 4 | MM1287 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 4.40e-05 | 238 | 103 | 7 | M2020 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 4.51e-05 | 50 | 103 | 4 | MM3805 | |
| Coexpression | HOLLERN_MICROACINAR_BREAST_TUMOR_UP | 5.27e-05 | 52 | 103 | 4 | MM968 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 5.27e-05 | 52 | 103 | 4 | MM3808 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 7.06e-05 | 56 | 103 | 4 | MM3852 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 7.57e-05 | 57 | 103 | 4 | MM3716 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 7.87e-05 | 261 | 103 | 7 | MM1277 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 8.67e-05 | 59 | 103 | 4 | MM3688 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 8.67e-05 | 59 | 103 | 4 | MM3704 | |
| Coexpression | LIN_NPAS4_TARGETS_UP | 8.71e-05 | 183 | 103 | 6 | MM767 | |
| Coexpression | GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP | 8.97e-05 | 184 | 103 | 6 | M6141 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 1.13e-04 | 120 | 103 | 5 | MM3710 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN | 1.30e-04 | 197 | 103 | 6 | M7255 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN | 1.38e-04 | 199 | 103 | 6 | M9323 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 1.38e-04 | 199 | 103 | 6 | M3445 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP | 1.42e-04 | 200 | 103 | 6 | M3404 | |
| Coexpression | YU_MYC_TARGETS_DN | 1.51e-04 | 68 | 103 | 4 | MM632 | |
| Coexpression | DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS | ZC3H12A STARD8 HLA-A HLA-C HLA-G BLNK HLA-H KCNK12 TNFRSF10A ELF4 | 1.57e-04 | 615 | 103 | 10 | MM3641 |
| Coexpression | GAURNIER_PSMD4_TARGETS | 1.99e-04 | 73 | 103 | 4 | M11428 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 2.09e-04 | 74 | 103 | 4 | MM3796 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 2.21e-04 | 75 | 103 | 4 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 2.21e-04 | 75 | 103 | 4 | MM3718 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 2.55e-04 | 223 | 103 | 6 | MM838 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE | 2.68e-04 | 225 | 103 | 6 | MM17079 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 3.11e-04 | 82 | 103 | 4 | MM3777 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 3.11e-04 | 82 | 103 | 4 | MM3858 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 3.41e-04 | 84 | 103 | 4 | MM1049 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 3.90e-04 | 87 | 103 | 4 | MM652 | |
| Coexpression | GSE6259_DEC205_POS_DC_VS_BCELL_UP | 3.95e-04 | 157 | 103 | 5 | M6770 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 4.06e-04 | 158 | 103 | 5 | MM3851 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 4.07e-04 | 88 | 103 | 4 | MM1087 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 4.43e-04 | 90 | 103 | 4 | MM3756 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 4.62e-04 | 91 | 103 | 4 | MM3720 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE | 5.24e-04 | 40 | 103 | 3 | M41037 | |
| ToppCell | Caecum-Dendritic_cell-cycling_DCs|Caecum / Region, Cell class and subclass | 4.56e-07 | 200 | 104 | 7 | 608be9bfe74f8d3202aa92b2905452a06f340f76 | |
| ToppCell | Caecum-(5)_Dendritic_cell-(52)_cycling_DCs|Caecum / shred on region, Cell_type, and subtype | 4.56e-07 | 200 | 104 | 7 | 3b04d08e9122c23f42f66bc74c06cf24e1693987 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Ptrf|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.13e-07 | 133 | 104 | 6 | a1bc34e5dda4ff4716b857931cc196f6770f58f4 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.88e-06 | 169 | 104 | 6 | 02fa66a91b8bd2bf971aec4f5ec58318b5bfdf14 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 178 | 104 | 6 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Cyp26b1_(Globus_Pallidus_Externus_(GP),_"Arkypallidal")-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.27e-06 | 49 | 104 | 4 | 389ad8def664f873ca0864df11e2b1dadd8eb9d0 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Cyp26b1_(Globus_Pallidus_Externus_(GP),_"Arkypallidal")--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.27e-06 | 49 | 104 | 4 | 8ec64217878b0cc289c8078c22729695ab5f5fa5 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Cyp26b1_(Globus_Pallidus_Externus_(GP),_"Arkypallidal")|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.27e-06 | 49 | 104 | 4 | 8d2ed325530dba342223d82e8b08251d782fd6b2 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 5.31e-06 | 188 | 104 | 6 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 5.31e-06 | 188 | 104 | 6 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 6.35e-06 | 194 | 104 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | cellseq-Endothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.35e-06 | 199 | 104 | 6 | 4757827efb393c429adec5079d18a173baf23d74 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.56e-06 | 200 | 104 | 6 | e0a003d2a5fd6adfcb817c9bc5dceb9c79e7491b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 7.56e-06 | 200 | 104 | 6 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 4.41e-05 | 166 | 104 | 5 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 4.41e-05 | 166 | 104 | 5 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.80e-05 | 169 | 104 | 5 | 9ab34f602d46ce87283d243b81621e8806504f43 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.80e-05 | 169 | 104 | 5 | 89fbafdb4628ce7a90c50398870e0f8ee90cfd91 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.80e-05 | 169 | 104 | 5 | 75d367eb35768d3063096e8866cea649dac3b1bd | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.94e-05 | 170 | 104 | 5 | 7dcb6319ba4d7b258dd0a17449d837800ef46ccc | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.94e-05 | 170 | 104 | 5 | 7377e59fba4bf97ba893ccf6b5e149b5152407be | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.94e-05 | 170 | 104 | 5 | e18211029e9ffad54458fd921f455172aad407c7 | |
| ToppCell | Control-B_cell-Plasmablast|Control / Disease group,lineage and cell class (2021.01.30) | 5.08e-05 | 171 | 104 | 5 | c09afc4b111b2b5acca75177554f6364ee02d37c | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 5.36e-05 | 173 | 104 | 5 | d815832f89f70662706620e3b03ebb1dabec0034 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.14e-05 | 178 | 104 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 178 | 104 | 5 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 6.47e-05 | 180 | 104 | 5 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 6.47e-05 | 180 | 104 | 5 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.64e-05 | 181 | 104 | 5 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.82e-05 | 182 | 104 | 5 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.00e-05 | 183 | 104 | 5 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.37e-05 | 185 | 104 | 5 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-05 | 186 | 104 | 5 | 422d24e3e1a9397bb7d5c7ef75de2fd7ae8e136d | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-05 | 186 | 104 | 5 | 65da0666a10a59f8cc379589860a2e98fe487754 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-05 | 186 | 104 | 5 | dc84fef1ca2f5d5d818b76a3321559e87d1c4a4d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.56e-05 | 186 | 104 | 5 | 8ea708070166c858cd9bd871670655b0114c32a5 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.75e-05 | 187 | 104 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-05 | 191 | 104 | 5 | 7235a4d1601c88a2c8af571a2c04ab56d32f1b9a | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.99e-05 | 193 | 104 | 5 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasmablast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.21e-05 | 194 | 104 | 5 | 81394fda763d3ff07f3f5ee2abd94ae0c73b6d39 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 195 | 104 | 5 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.67e-05 | 196 | 104 | 5 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 9.67e-05 | 196 | 104 | 5 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 197 | 104 | 5 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.90e-05 | 197 | 104 | 5 | 4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 197 | 104 | 5 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.90e-05 | 197 | 104 | 5 | 2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.90e-05 | 197 | 104 | 5 | 0f37afad46b94c748a149d9ee681472d7a3e6937 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 198 | 104 | 5 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | BAL-Severe|BAL / Compartment, Disease Groups and Clusters | 1.01e-04 | 198 | 104 | 5 | f63cfcc57f46094ea0673bbc70ea443ebaca6176 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 198 | 104 | 5 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-04 | 199 | 104 | 5 | 9364199c5b4540ce2e14341fd9d504b695f8249d | |
| ToppCell | mLN-Macrophage-Macrophage|mLN / Region, Cell class and subclass | 1.04e-04 | 199 | 104 | 5 | 6bbec8450afb30347b07da28401a698fc51a3c53 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-04 | 199 | 104 | 5 | 307d29816a224193aa3d8c4540e128b2ad2e90b9 | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.04e-04 | 199 | 104 | 5 | aa6f1390283617c7f9aaf91d379024832ea24a9e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 199 | 104 | 5 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.04e-04 | 199 | 104 | 5 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | mLN-(6)_Macrophage-(60)_Macrophage|mLN / shred on region, Cell_type, and subtype | 1.04e-04 | 199 | 104 | 5 | 1ea28b832c6173b1b58da432aaf21e6cd291561e | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.04e-04 | 199 | 104 | 5 | 2ac716f887687b5109fb9feced75d5c62646a268 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 1.04e-04 | 199 | 104 | 5 | c051cc3e42cfa2ec09fd8dae1172af350bb2dfcb | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 200 | 104 | 5 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | systemic_lupus_erythematosus|World / PBMC cell types (v2) per disease, treatment status, and sex | 1.06e-04 | 200 | 104 | 5 | d5beabeb3545750e14620064a92c72eff9d9572d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-04 | 200 | 104 | 5 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.06e-04 | 200 | 104 | 5 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Caecum-Macrophage-Macrophage|Caecum / Region, Cell class and subclass | 1.06e-04 | 200 | 104 | 5 | 99dcf07b17ecf90d596f3b8a12d5b7aae2a351d5 | |
| ToppCell | distal-Endothelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 200 | 104 | 5 | b17c9607d4986f8f1facc6b564d4c15c48e58915 | |
| ToppCell | Caecum-(6)_Macrophage-(60)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.06e-04 | 200 | 104 | 5 | 67b6cdeb07ffc5c9af7a3e738dd31256cf391e98 | |
| ToppCell | Caecum-(6)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.06e-04 | 200 | 104 | 5 | 2ce3930645c3daf6be578f7881e57a58df61e75c | |
| ToppCell | Caecum-Macrophage|Caecum / Region, Cell class and subclass | 1.06e-04 | 200 | 104 | 5 | d83209559187a4419df2508ecc5eb9f7d72fced3 | |
| ToppCell | distal-2-Endothelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 200 | 104 | 5 | bc1781cff7a4602057a59ef65cf16c3a9459c628 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-04 | 200 | 104 | 5 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.06e-04 | 200 | 104 | 5 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendendrocytes_NG2_cells_(Tnr-Cspg5)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 109 | 104 | 4 | 87f647cfebbb7de725e434cc27058e1c6accbb90 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P3-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 109 | 104 | 4 | e3696d84da1dcd15f15d0434ea9d1955f2af22d6 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendendrocytes_NG2_cells_(Tnr-Cspg5)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 109 | 104 | 4 | 6678036ff66c825a18d2506e33be421c27cf82e1 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P3|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 109 | 104 | 4 | c9d1e69f9841135f4d114563a293a69a8ba5f965 | |
| Computational | Genes in the cancer module 293. | 3.17e-05 | 12 | 58 | 3 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 5.20e-05 | 14 | 58 | 3 | MODULE_143 | |
| Computational | Neighborhood of INPP5D | 8.05e-05 | 43 | 58 | 4 | GNF2_INPP5D | |
| Computational | Neighborhood of HLA-C | 1.15e-04 | 47 | 58 | 4 | GNF2_HLA_C | |
| Computational | Neighborhood of CD53 | 2.61e-04 | 58 | 58 | 4 | GNF2_CD53 | |
| Computational | Neighborhood of STAT6 | 8.49e-04 | 79 | 58 | 4 | GNF2_STAT6 | |
| Computational | Neighborhood of VAV1 | 9.38e-04 | 36 | 58 | 3 | GNF2_VAV1 | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.87e-06 | 196 | 102 | 8 | 6295_DN | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.27e-06 | 7 | 99 | 3 | DOID:0081267 (implicated_via_orthology) | |
| Disease | serum IgE measurement | 6.49e-05 | 64 | 99 | 4 | EFO_0004579 | |
| Disease | beta-2 microglobulin measurement | 6.01e-04 | 11 | 99 | 2 | EFO_0005197 | |
| Disease | IgG galactosylation measurement | 7.20e-04 | 12 | 99 | 2 | EFO_0008425 | |
| Disease | autism spectrum disorder, schizophrenia | 8.36e-04 | 327 | 99 | 6 | EFO_0003756, MONDO_0005090 | |
| Disease | neutrophil count, basophil count | 9.67e-04 | 224 | 99 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | femoral neck bone geometry | 9.88e-04 | 14 | 99 | 2 | EFO_0004511 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.43e-03 | 144 | 99 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | upper aerodigestive tract neoplasm | 1.46e-03 | 246 | 99 | 5 | EFO_0004284 | |
| Disease | syndrome (implicated_via_orthology) | 1.65e-03 | 18 | 99 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | neutrophil count | PRUNE2 HLA-A COPA HLA-C OLFML2B HLA-G GATA2 NSD1 MARCHF7 PCDHA5 PCDHA2 WDR26 | 2.28e-03 | 1382 | 99 | 12 | EFO_0004833 |
| Disease | S-7-hydroxywarfarin to S-warfarin ratio measurement | 2.59e-03 | 81 | 99 | 3 | EFO_0803334 | |
| Disease | reticulocyte count | HLA-A HLA-C HLA-G HLA-H ST6GAL1 ABCB4 TFR2 PIKFYVE ZNF469 MAST1 | 2.69e-03 | 1045 | 99 | 10 | EFO_0007986 |
| Disease | drug-induced liver injury | 2.93e-03 | 24 | 99 | 2 | EFO_0004228 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.03e-03 | 291 | 99 | 5 | EFO_0008317, EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DPGAASSWAGLQSLK | 226 | Q6ZR03 | |
| PATASGSAVTAAGRW | 1396 | Q5SNV9 | |
| AAAPERKTSVWTGGS | 371 | Q9Y614 | |
| GPQSSAAPWAGSEKA | 11 | Q7RTU5 | |
| SGPSLRKDGDVSAAW | 21 | Q9H4I9 | |
| GGASARAIWEAVKSA | 436 | B6SEH9 | |
| ASIGSWSGASDKAGI | 1136 | Q5H9R4 | |
| LDATSAGEKAPSPWG | 871 | Q76LX8 | |
| PADRTDGSVQAAAWG | 86 | Q8NCD3 | |
| PEQKRKAGSTSWTGF | 636 | Q9NW13 | |
| EQSPWALGKASSRAG | 2621 | Q96L73 | |
| AGASAGLEAKPRIWS | 356 | P78413 | |
| ETRPAGDGTFQKWAA | 256 | P01893 | |
| ESGQAPKASSRAWVG | 671 | Q9Y5H9 | |
| PKASSRAWVGAAGSE | 676 | Q9Y5H9 | |
| ETRPAGDGTFQKWAA | 256 | P17693 | |
| PSGSDLWAGAAVAKP | 581 | Q96RG2 | |
| GSAGSLWIAAERSSP | 241 | Q5SZI1 | |
| AGNLSKATLWAEPGS | 41 | A6NI73 | |
| ARGISGSAGKALAVW | 221 | Q9BYB4 | |
| PDGWTAVTRDGKRSA | 341 | P53582 | |
| VRGSEAREGKSPSWF | 1021 | Q9BXT6 | |
| SGKRGSEEAPGVAWS | 26 | C0HLZ6 | |
| AASRGGPKVVFGNSW | 2311 | Q9UKN7 | |
| SRSAPQGKGSSSWEK | 336 | Q99607 | |
| QPASSAGKRASDAWG | 416 | O95208 | |
| AGKRASDAWGAVSTT | 421 | O95208 | |
| VSAVLAEASWGSPSA | 211 | Q0VG99 | |
| ATAGWSAAGKSVPQD | 426 | Q10570 | |
| ETRPAGDGTFQKWAA | 256 | P10321 | |
| SSSGGKIWQGEPARV | 41 | O15428 | |
| GKIRPRSWSSGSSEA | 281 | Q92628 | |
| RGSALSEADSLAGWK | 196 | Q9HB15 | |
| GNKTVLGWESRASGP | 676 | Q5T7B8 | |
| SWAKSAGAKSSGGRE | 61 | Q9UK76 | |
| SATWPRATKSLAKGG | 256 | O94854 | |
| VSGAGPSQAALWAKS | 36 | Q15274 | |
| SGRAPRGGSADAAWK | 96 | Q9ULI3 | |
| ARDGGSPSLWATASV | 426 | Q9Y5H7 | |
| NLARKSSSGPVWSGA | 306 | Q9NYZ3 | |
| WRGGSPEIKRFSASE | 766 | Q9Y2H9 | |
| AKNGTAWRPTSAEGD | 6 | P21439 | |
| HSSPWQARGGKSGAA | 1851 | Q9Y2I7 | |
| APKKSRAAGGGASWE | 6 | Q9UP38 | |
| PWLDGGKAALSAAAA | 96 | P23769 | |
| KDGTGWIATRPASEQ | 626 | Q8N6C5 | |
| PGTASGRNSGAWETK | 221 | Q8WV28 | |
| SASTPTLWDGKKRGD | 1471 | Q9Y6J0 | |
| PAASSAAGDAGWPNK | 71 | Q8IXL6 | |
| DAPEGKRSSGLTAVW | 406 | P53621 | |
| PGLGASWRSREAAAA | 21 | Q96SL1 | |
| DSGARPDEAVSWGKI | 316 | P49366 | |
| AALSASAGLWSPAKE | 16 | P22466 | |
| SPAKEKRGWTLNSAG | 26 | P22466 | |
| ETRPAGDGTFQKWAA | 256 | P04439 | |
| IIPSGWNSADGKSDK | 506 | Q9H992 | |
| TGFSGDGRAIWSKNP | 51 | Q86Z14 | |
| KRTGFSSSQAWSRPG | 401 | Q6PII3 | |
| AGRSTWLKVGEAPAD | 686 | Q86VF2 | |
| TAIKAPGWANSSAGS | 96 | Q86VB7 | |
| SFVPSWGATATGARK | 166 | O95954 | |
| AFGKGLSNWRPSGSS | 186 | Q96G25 | |
| GGVPAWAETTKRKTS | 191 | Q9Y5J1 | |
| KRSSPETGTTGDVAW | 1786 | Q8WUY3 | |
| LDARDSGPGWSGKTV | 2646 | Q8WUY3 | |
| LSSWFSAPTVGAGRK | 201 | Q8N3T6 | |
| SRVSAPAGGKASWGA | 696 | Q9NPR2 | |
| CSWSPDGSKIAAGSA | 291 | Q96DI7 | |
| ESEKGAGPRSAGWRA | 136 | A6NIN4 | |
| TKAGPWGRCAVVSSA | 176 | P15907 | |
| PQGTKRVGAGDTSDW | 346 | Q9BUA3 | |
| LGAEDRAATSAKSWP | 221 | Q92968 | |
| GAAALATARSLWGTP | 11 | Q9NSE4 | |
| TVRTDSLGKDAPAGW | 456 | Q68BL8 | |
| SAGGSGANTRKAWEA | 186 | Q92502 | |
| KPGRAGSSLTSFQWR | 3496 | Q9NRC6 | |
| SSADVSKVNRWGPGR | 771 | Q9Y2K9 | |
| GANPWSKLSGAKFSR | 41 | Q8TEV9 | |
| SQRSSSPVGLAKWFG | 946 | Q9NRA8 | |
| AVGLSSWKASPGKVT | 6 | Q96JD6 | |
| WEKGNVFSSPTAAGT | 716 | Q05682 | |
| SSFEKWEIARGNTPG | 721 | Q0P6D6 | |
| SVATSLKAPGWDGAA | 16 | Q9NQ32 | |
| QSISAPGSGIWSDGK | 311 | A5YKK6 | |
| DAGDKPATFVGSRQW | 336 | Q9NUQ7 | |
| VDIRPAGGSDKWTAT | 1031 | Q9BXT8 | |
| QERGGGSKPWSARTE | 171 | Q6P1L6 | |
| SPWGRAGSLAKEQAS | 541 | Q5D1E8 | |
| AWVSAKDAGFSSPDG | 441 | Q8TAF3 | |
| SKPRSASGDTVFWGE | 296 | Q96PV0 | |
| ASPATLAGATAVSEW | 421 | O14776 | |
| SSWAAKAPGASSREE | 71 | O95238 | |
| GAGSEWRKPGAVSFA | 26 | Q9BV97 | |
| NPAGSSSSLGTRKWE | 156 | O15391 | |
| SKARGLWPFASAAGG | 6 | O75896 | |
| DALQPGSTRVAKGWS | 31 | A1A519 | |
| WKVRAGSDKLGSFPS | 256 | Q9NRS4 | |
| PSSSSLDTWGAGRKL | 336 | O94885 | |
| GTEAAAATPSKVWGS | 26 | O00220 | |
| AATPSKVWGSSAGRI | 31 | O00220 | |
| GASARGFWGPRETKA | 2721 | Q96JG9 | |
| SKGLQRGSPAGAWDS | 986 | Q8N398 | |
| GWGLPEARSKESVSF | 31 | Q16587 | |
| TAPRKGTVWSLSGSD | 701 | Q8WUA4 | |
| TKGRWPLTASAAGLS | 106 | Q9ULZ0 | |
| SVAWNPDGKRFVTGG | 451 | Q9H7D7 | |
| WSSRGLPGDQADTAA | 21 | Q96NL1 | |
| RKASALGPGAGAWET | 636 | P0DP72 | |
| AQRDAWGPGAAKSAV | 431 | Q9UP52 | |
| GSGQSSAGLAALRKW | 2596 | Q9P2D8 | |
| GTRTKASPVWGRDGN | 106 | Q8N3U1 |